Sanofi (SNY) reported Q4 business earnings Thursday of 1.31 euros ($1.36) per share, down from 1.54 euros a year earlier.
Analysts' estimates were not readily available for comparison.
Revenue for the quarter ended Dec. 31 was 10.56 billion euros, up from 9.69 billion euros a year earlier.
Analysts surveyed by FactSet expected 10.83 billion euros.
For 2025, the French biopharmaceutical giant expects sales growth percentage in the mid to high single digits. Analysts polled by FactSet expect 46.33 billion euros.
Sanofi said it intends to launch a 5 billion euro share buyback program this year.
Shares of the company were up nearly 3% in Thursday's premarket activity.
Price: 53.75, Change: +1.60, Percent Change: +3.07
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。